183 related articles for article (PubMed ID: 37692575)
21. The Emerging Role of Exosomes in Oral Squamous Cell Carcinoma.
Lu Y; Zheng Z; Yuan Y; Pathak JL; Yang X; Wang L; Ye Z; Cho WC; Zeng M; Wu L
Front Cell Dev Biol; 2021; 9():628103. PubMed ID: 33718365
[TBL] [Abstract][Full Text] [Related]
22. MiR-155 Inhibitor-Laden Exosomes Reverse Resistance to Cisplatin in a 3D Tumor Spheroid and Xenograft Model of Oral Cancer.
Sayyed AA; Gondaliya P; Mali M; Pawar A; Bhat P; Khairnar A; Arya N; Kalia K
Mol Pharm; 2021 Aug; 18(8):3010-3025. PubMed ID: 34176265
[TBL] [Abstract][Full Text] [Related]
23. Exosomal long noncoding RNAs MAGI2-AS3 and CCDC144NL-AS1 in oral squamous cell carcinoma development via the PI3K-AKT-mTOR signaling pathway.
Li C; Guo H; Xiong J; Feng B; Zhu P; Jiang W; Jiang P; Su X; Huang X
Pathol Res Pract; 2022 Dec; 240():154219. PubMed ID: 36401978
[TBL] [Abstract][Full Text] [Related]
24. Liquid biopsy in the assessment of microRNAs in oral squamous cell carcinoma: A systematic review.
Palaia G; Pippi R; Rocchetti F; Caputo M; Macali F; Mohsen A; Del Vecchio A; Tenore G; Romeo U
J Clin Exp Dent; 2022 Oct; 14(10):e875-e884. PubMed ID: 36320672
[TBL] [Abstract][Full Text] [Related]
25. Long Noncoding RNAs in the Metastasis of Oral Squamous Cell Carcinoma.
Xu Y; Jiang E; Shao Z; Shang Z
Front Oncol; 2020; 10():616717. PubMed ID: 33520725
[TBL] [Abstract][Full Text] [Related]
26. Glycolytic pathway candidate markers in the prognosis of oral squamous cell carcinoma: a systematic review with meta-analysis.
Mattos SEC; Diel LF; Bittencourt LS; Schnorr CE; Gonçalves FA; Bernardi L; Lamers ML
Braz J Med Biol Res; 2021; 54(3):e10504. PubMed ID: 33503201
[TBL] [Abstract][Full Text] [Related]
27. A circulating microRNA panel as a novel dynamic monitor for oral squamous cell carcinoma.
Piao Y; Jung SN; Lim MA; Oh C; Jin YL; Kim HJ; Nguyen QK; Chang JW; Won HR; Koo BS
Sci Rep; 2023 Feb; 13(1):2000. PubMed ID: 36737651
[TBL] [Abstract][Full Text] [Related]
28. Epidermal growth factor/epidermal growth factor receptor signaling blockage inhibits tumor cell-derived exosome uptake by oral squamous cell carcinoma through macropinocytosis.
Sasabe E; Tomomura A; Liu H; Sento S; Kitamura N; Yamamoto T
Cancer Sci; 2022 Feb; 113(2):609-621. PubMed ID: 34874595
[TBL] [Abstract][Full Text] [Related]
29. Cancer‑associated fibroblast‑derived exosomal miR‑382‑5p promotes the migration and invasion of oral squamous cell carcinoma.
Sun LP; Xu K; Cui J; Yuan DY; Zou B; Li J; Liu JL; Li KY; Meng Z; Zhang B
Oncol Rep; 2019 Oct; 42(4):1319-1328. PubMed ID: 31364748
[TBL] [Abstract][Full Text] [Related]
30. Role of Porphyromonas gingivalis in oral squamous cell carcinoma development: A systematic review.
Lafuente Ibáñez de Mendoza I; Maritxalar Mendia X; García de la Fuente AM; Quindós Andrés G; Aguirre Urizar JM
J Periodontal Res; 2020 Jan; 55(1):13-22. PubMed ID: 31529626
[TBL] [Abstract][Full Text] [Related]
31. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
[TBL] [Abstract][Full Text] [Related]
32. Exosomal CircGDI2 Suppresses Oral Squamous Cell Carcinoma Progression Through the Regulation of MiR-424-5p/SCAI Axis.
Zhang Y; Tang K; Chen L; Du M; Qu Z
Cancer Manag Res; 2020; 12():7501-7514. PubMed ID: 32943917
[TBL] [Abstract][Full Text] [Related]
33. The clinical implications of circulating microRNAs as potential biomarkers in screening oral squamous cell carcinoma.
Gao H; Shen Y; Feng Z; Cai Y; Yang J; Zhu Y; Peng Q
Front Oncol; 2022; 12():965357. PubMed ID: 36465364
[TBL] [Abstract][Full Text] [Related]
34. Application of a Persistent Heparin Treatment Inhibits the Malignant Potential of Oral Squamous Carcinoma Cells Induced by Tumor Cell-Derived Exosomes.
Sento S; Sasabe E; Yamamoto T
PLoS One; 2016; 11(2):e0148454. PubMed ID: 26849680
[TBL] [Abstract][Full Text] [Related]
35. Screening of oral squamous cell carcinoma by serum changes: A systematic review and meta-analysis.
Keshani F; Khalesi S; Aghaz A; Farhang M; Akbari N
Dent Res J (Isfahan); 2021; 18():88. PubMed ID: 34760079
[TBL] [Abstract][Full Text] [Related]
36. Potential Markers from Serum-Purified Exosomes for Detecting Oral Squamous Cell Carcinoma Metastasis.
Li C; Zhou Y; Liu J; Su X; Qin H; Huang S; Huang X; Zhou N
Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1668-1681. PubMed ID: 31350263
[TBL] [Abstract][Full Text] [Related]
37. Circulating miRNAs from blood, plasma or serum as promising clinical biomarkers in oral squamous cell carcinoma: A systematic review of current findings.
Troiano G; Boldrup L; Ardito F; Gu X; Lo Muzio L; Nylander K
Oral Oncol; 2016 Dec; 63():30-37. PubMed ID: 27938997
[TBL] [Abstract][Full Text] [Related]
38. M2 Macrophages-Derived Exosomal miRNA-23a-3p Promotes the Progression of Oral Squamous Cell Carcinoma by Targeting PTEN.
Li J; Bao Y; Peng S; Jiang C; Zhu L; Zou S; Xu J; Li Y
Curr Issues Mol Biol; 2023 Jun; 45(6):4936-4947. PubMed ID: 37367063
[TBL] [Abstract][Full Text] [Related]
39. Salivary Exosomal miRNA-1307-5p Predicts Disease Aggressiveness and Poor Prognosis in Oral Squamous Cell Carcinoma Patients.
Patel A; Patel S; Patel P; Mandlik D; Patel K; Tanavde V
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142544
[No Abstract] [Full Text] [Related]
40. MicroRNA-18a regulates the metastatic properties of oral squamous cell carcinoma cells via HIF-1α expression.
Kim S; Park S; Oh JH; Lee SS; Lee Y; Choi J
BMC Oral Health; 2022 Sep; 22(1):378. PubMed ID: 36064348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
